School of Medicine
Showing 1,101-1,120 of 1,617 Results
-
Edwin Omar Rivera-López
Postdoctoral Scholar, Infectious Diseases
BioEdwin Omar Rivera-López is a Postdoctoral Scholar in the Bollyky Lab at Stanford University. He earned his dual-title Ph.D. in Food Science and Clinical and Translational Sciences from The Pennsylvania State University under the mentorship of Dr. Edward G. Dudley, where he studied bacteriophage–host interactions in Escherichia coli O157 using functional genomics to identify the genetic determinants of phage adsorption and host defense. His current research focuses on developing phage–antibiotic therapies for the treatment of polymicrobial bacterial infections associated with cystic fibrosis.
-
Desirée Rodrigues Plaça
Postdoctoral Scholar, Infectious Diseases
Current Research and Scholarly InterestsI am studying Flaviviridae viruses, focusing on dengue. My research explores T cell and myeloid dysregulation in severe dengue to improve vaccines and identify biomarkers. I'm characterizing T cell responses to DENV, and the regulatory immune response through integrative systems analysis. My ultimate goal is to contribute to the development of improved diagnostic tools and vaccines for pediatric infectious diseases, particularly in endemic regions like Brazil.
-
Benjamin Rolles
Postdoctoral Scholar, Hematology
BioMD/Research Fellow
@MullallyLab @StanfordMed @VAPaloAlto @BrighamHeme @BrighamResearch @HarvardMed
Studied
@UniklinikAachen @RWTH
Interested in MPN & Myeloid Malignancies -
Kevin Rose
Postdoctoral Scholar, Structural Biology
Current Research and Scholarly InterestsI am interested in studying organelle dysfunction and host cell responses at the highest resolution possible in natively preserved tissues. To do this, I couple correlative light and cryo-Electron Tomography (cryo-ET) and perform ultrastructural analysis of healthy and diseased organelles. This technique hopes to uncover new molecular details of pathophysiology so that we can improve our understanding of diseases such as cancer and neurodegeneration to improve the rationale therapeutic design.
